- Aleglitazar
Chembox new
ImageFile = Aleglitazar.svg
ImageSize = 350px
IUPACName = (2S)-2-methoxy-3- [4- [2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy] -7-benzothiophenyl] propanoic acid
OtherNames = Ro-0728804, R-1439
Section1 = Chembox Identifiers
CASNo=475479-34-6
PubChem=10274777
SMILES=CC1=C(CCOc2ccc(C [C@H] (OC)C(O [H] )=O)c3c2C=CS3)N=C(c4ccccc4)O1
Section2 = Chembox Properties
Formula=C24H23NO5S
MolarMass=437.50812
Appearance=
Density=
MeltingPt=
BoilingPt=
Solubility=
Section3 = Chembox Hazards
MainHazards=
FlashPt=
Autoignition=Aleglitazar is a
peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, which is being developed byHoffmann–La Roche for the treatment of type II diabetes.cite web | url = http://www.ama-assn.org/ama1/pub/upload/mm/365/aleglitazar.pdf | title = Statement on a nonproprietary name adopted by the USAN Council: Aleglitazar | author = | authorlink = | coauthors = | date = | format = | work = United States Adopted Names | publisher = American Medical Association | pages = | language = | archiveurl = | archivedate = | quote = | accessdate = 2008-08-17] It is currently in phase II clinical trials.cite web | url = http://clinicaltrials.gov/ct2/show/NCT00388518?cntry1=EU%3ARO&rank=50 | title = A Study of Aleglitazar in Patients With Type 2 Diabetes | accessdate = 2008-03-19 | author = ClinicalTrials.gov | authorlink = | coauthors = | date = | format = | work = | publisher = United States National Institutes of Health | pages = | language = | archiveurl = | archivedate = | quote = ]References
Wikimedia Foundation. 2010.
